JAM-B/VE-JAM Antibody (988905) [HRP]

• Reactivity: Hu
• Applications: Flow, B/N
• Clone: 988905
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: HRP

JAM-B/VE-JAM Antibody (988905) [HRP] Summary

• Immunogen: Mouse myeloma cell line NS0-derived recombinant human JAM‑B/VE‑JAM
  Phe29-Asn236
  Accession # P57087
• Specificity: Detects human JAM/VE-JAM in direct ELISAs
• Isotype: IgG2a
• Clonality: Monoclonal
• Host: Mouse

Applications/Dilutions

• Dilutions:
  • Flow Cytometry
  • Neutralization
• Application Notes: Optimal dilution of this antibody should be experimentally determined.

Packaging, Storage & Formulations

• Storage: Store at 4C in the dark.
• Buffer: PBS
• Preservative: No Preservative

Alternate Names for JAM-B/VE-JAM Antibody (988905) [HRP]

• C21orf43
• CD322 antigen
• CD322
• JAM2
• JAMB
• JAM-B
• JAM-BJAM-IT/VE-JAM
• junctional adhesion molecule 2JAM-2
• junctional adhesion molecule B
• PRO245
• Vascular endothelial junction-associated molecule
• VE-JAM
• VE-JAMVEJAMCD322

Background

Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely through the paracellular space. The protein encoded by this immunoglobulin superfamily gene member is localized in the tight junctions between high endothelial cells. It acts as an adhesive ligand for interacting with a variety of immune cell types and may play a role in lymphocyte homing to secondary lymphoid organs.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.